We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Adjunctive Quetiapine in the Treatment of Refractory Social Anxiety Disorder in Adults

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01224067
First Posted: October 19, 2010
Last Update Posted: April 18, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Cambridge Health Alliance
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2008
  Primary Completion Date: July 2008 (Final data collection date for primary outcome measure)